Skip to main content
. Author manuscript; available in PMC: 2010 Jan 1.
Published in final edited form as: Semin Radiat Oncol. 2009 Jan;19(1):53–62. doi: 10.1016/j.semradonc.2008.09.010

Figure 2.

Figure 2

Study schema for single institutional study (Duke 7077) evaluating the feasibility of combining bevacizumab and erlotinib in combination with cisplatin-based chemotherapy and split course hyperfractionated radiotherapy in patients with locally advanced HNSCC.